Alight, the benefits-administration business that Aon engineered out in the 2020 SPAC deal with Foley Trasimene, reported a second quarter that management framed as another beat - revenue and adjusted EBITDA both "exceeded expectations," in the company's words - while the stock sold off hard anyway. That gap between the beat and the reaction is the quarter's real story. The numbers did improve sharply on one axis: net loss attributable to Alight narrowed from a $1,073 million loss a year ago to $10 million this quarter, and GAAP diluted EPS swung from a $40.61 loss to a $0.38 loss on the split-adjusted basis. But almost all of that swing is a presentational artifact - the prior-year quarter carried a $983 million non-cash goodwill impairment that does not repeat. Strip that and the underlying business is still shrinking: revenue fell 3.2% to $511 million, recurring revenue fell 4.3%, and adjusted EBITDA margin compressed to 18.0% from 24.1% a year ago. The company guided adjusted EBITDA down roughly 27% for the full year against 2025, and the 1-for-20 reverse stock split that took effect on June 30 is the clearest mark yet of how far the equity had already fallen. At a market value near $364 million against roughly $1.78 billion of net debt, Q2 was a leveraged, cash-generative, organically-contracting quarter - a beat that the market, which dropped the shares about 12% on the print before drifting lower, chose not to believe as a signal of a turn.
The useful frame for the quarter splits into three acts. The accounting cleaned up - no repeat goodwill impairment, a $46 million non-cash gain on the tax receivable agreement, and $101 million of first-half free cash flow on a $29 million GAAP net loss show the cash engine still turns. The operating base kept contracting - recurring revenue down 4.3%, the fourth consecutive quarter of organic decline, with management bluntly stating the drag from prior-year client losses and lower bookings will continue through 2026. And the balance sheet stays heavy - total debt of $1,996 million, a $330 million revolver fully untouched, and a dividend suspended since February as cash is redirected to deleveraging. The question is not whether this company throws off cash - it does - but whether a shrinking recurring-revenue base can absorb AI and modernization investment, hold margins, and pay down 4.4x net debt without the equity continuing to re-rate lower. The stock at roughly 5x forward enterprise value to adjusted EBITDA is the market pricing a workout, not a compounder.